✦ LIBER ✦

Reply to: Lipoprotein (a) and chronic obstructive pulmonary disease

✍ Scribed by Patrizia Ferroni; Pier Paolo Gazzaniga; Corrado Cordova; Stefania Basili; Cesare Alessandri

Book ID: 119434178
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 48 KB
Volume: 155
Category: Article
ISSN: 0021-9150
DOI: 10.1016/s0021-9150(00)00747-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lipoprotein (a) and chronic obstructive

Lipoprotein (a) and chronic obstructive pulmonary disease

✍ D.N Kiortsis; A Evangelou; M.S Elisaf 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Roflumilast for chronic obstructive pulm

Roflumilast for chronic obstructive pulmonary disease – Author's reply

✍ Klaus F Rabe 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 45 KB

Chronic Obstructive Pulmonary Disease

✍ Shoab A. Nazir, Dr Marcia L. Erbland 📂 Article 📅 2009 🏛 Springer International Publishing AG 🌐 English ⚖ 234 KB

Chronic Obstructive Pulmonary Disease

✍ Neil R. MacIntyre Jr. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Chronic Obstructive Pulmonary Disease

✍ Mary Jo Goolsby 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB

Chronic obstructive pulmonary disease

📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB

Chronic obstructive pulmonary disease (COPD) involves progressive pulmonary airflow limitation that is not completely reversible, and is associated with an abnormal airway inflammatory response. COPD affects over 11 million Americans and is the fourth most common cause of death in the United States